Skip to main content

Advertisement

SpringerLink
Log in

A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score

  • CE - LETTER TO THE EDITOR
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Agnelli G (1997) Venous thromboembolism and cancer: a two way clinical association. Thromb Haemost 78:117–120

    PubMed  CAS  Google Scholar 

  2. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902–4907

    Article  PubMed  CAS  Google Scholar 

  3. Barni S, La Bianca R, Agnelli G, Bonizzoni E, Verso M, Mandalà M, Brighenti M, Petrelli F, Bianchini C, Perrone T, Gasparini G (2011) Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study. J Transl Med 9:179–185

    Article  PubMed  CAS  Google Scholar 

  4. Agnelli G, Gussoni G, Bianchini C, Verso M, Mandalà M, Cavanna L, Barni S, Labianca R, Buzzi F, Scambia G, Passalacqua R, Ricci S, Gasparini G, Lorusso V, Bonizzoni E (2009) For the PROTECHT Investigators. Nadroparin for the prevention of thromboembolic events in outpatients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol 10:943–949

    Article  PubMed  CAS  Google Scholar 

  5. Streiff MB, Bockenstedt PL, Cataland PR, Chesney C, Eby C, Fanikos J, Fogarty PF, Gao S, Garcia-Aguilar J, Goldhaber SZ, Hassoun H, Hendrie P, Holmstrom B, Jones KA, Kuderer N, Lee JT, Millenson MM, Neff AT, Ortel TL, Smith JL, Yee GC, Zakarija A (2011) Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw 9:714–775

    CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Sezione di Medicina Interna e Cardiovascolare—Stroke Unit, Dipartimento di Medicina Interna, Università di Perugia, Via Gerardo Dottori, 06100, Perugia, Italy

    Melina Verso & Giancarlo Agnelli

  2. Medical Oncology Department, Azienda Ospedaliera Treviglio—Caravaggio, Treviglio, Italy

    Sandro Barni

  3. Oncology Department, San Filippo Neri Hospital, Rome, Italy

    Giampietro Gasparini

  4. Oncology and Hematology Department, Medical Oncology Unit, Ospedali Riuniti, Bergamo, Italy

    Roberto LaBianca

Authors
  1. Melina Verso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giancarlo Agnelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandro Barni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giampietro Gasparini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roberto LaBianca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Melina Verso.

Additional information

For the Protecht investigators.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verso, M., Agnelli, G., Barni, S. et al. A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. Intern Emerg Med 7, 291–292 (2012). https://doi.org/10.1007/s11739-012-0784-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-012-0784-y

Keywords

Search

Navigation